منابع مشابه
Thrombolysis in Pulmonary Embolism
Correspondence to Won-Il Choi, M.D. Department of Internal Medicine, Keimyung University School of Medicine, 216 Dalseong-ro, Jung-gu, Daegu 700-712, Korea Tel: +82-53-250-7572, Fax: +82-53-250-7434, E-mail: [email protected] Copyrightc 2013 The Korean Association of Internal Medicine This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial L...
متن کاملThrombolysis in acute pulmonary thromboembolism.
Acute pulmonary embolism (PE) is a common clinical condition with presentations that may vary from asymptomatic subsegmental emboli to massive vascular obstruction and shock with high risk of death. Identifying patients at highest risk for death is critical to select those who would benefit most from thrombolytic therapy. New and evolving clinical prediction models, serum tests, and imaging mod...
متن کاملLate Thrombolysis in Massive Pulmonary Thromboembolism
Pulmonary thromboembolism (PTE) remains a diagnostic and therapeutic challenge for physicians. Anticoagulation with heparin remains as the cornerstone in its management, reserving thrombolysis for cases with hemodynamic impairment. The later has been associated with haemorrhagic complications and has proved beneficial when initiated within the first 48 hours of PTE; but there is little evidence...
متن کاملSpontaneous pulmonary hemorrhage following coronary thrombolysis.
Excessive bleeding is a major concern during the administration of thrombolytic therapy. Although the great majority of these events occur at sites of vascular interruption, major gastrointestinal, retroperitoneal, genitourinary, and central nervous system hemorrhage are known to occur. We present a patient who developed spontaneous pulmonary hemorrhage during thrombolytic therapy. Lack of reco...
متن کاملLung endothelium targeting for pulmonary embolism thrombolysis.
BACKGROUND Pulmonary embolism occurs frequently in hospitalized patients. Thrombolytic therapy, currently used as the major treatment, has often been associated with severe bleeding complications and has thereby been life-threatening. We have developed a novel therapeutic method based on our newly created pulmonary endothelium-specific antibody. METHODS AND RESULTS We isolated membrane protei...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Archives of Cardiovascular Diseases Supplements
سال: 2013
ISSN: 1878-6480
DOI: 10.1016/s1878-6480(13)71257-6